» Articles » PMID: 30103242

Genome-Wide Association Study Links Receptor Tyrosine Kinase Inhibitor Sprouty 2 to Thrombocytopenia After Coronary Artery Bypass Surgery

Overview
Journal Thromb Haemost
Publisher Thieme
Date 2018 Aug 14
PMID 30103242
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction:  Thrombocytopenia after cardiac surgery independently predicts stroke, acute kidney injury and death. To understand the underlying risks and mechanisms, we analysed genetic variations associated with thrombocytopenia in patients undergoing coronary artery bypass grafting (CABG) surgery.

Materials And Methods:  Study subjects underwent isolated on-pump CABG surgery at Duke University Medical Center. Post-operative thrombocytopenia was defined as platelet count < 100 × 10/L. Using a logistic regression model adjusted for clinical risk factors, we performed a genome-wide association study in a discovery cohort ( = 860) and validated significant findings in a replication cohort ( = 296). Protein expression was assessed in isolated platelets by immunoblot.

Results:  A total of 63 single-nucleotide polymorphisms met a priori discovery thresholds for replication, but only 1 (rs9574547) in the intergenic region upstream of sprouty 2 () met nominal significance in the replication cohort. The minor allele of rs9574547 was associated with a lower risk for thrombocytopenia (discovery cohort, odds ratio, 0.45, 95% confidence interval, 0.30-0.67,  = 9.76 × 10) with the overall association confirmed by meta-analysis (meta- = 7.88 × 10). Immunoblotting demonstrated expression of SPRY2 and its dynamic regulation during platelet activation. Treatment with a functional SPRY2 peptide blunted platelet extracellular signal-regulated kinase (ERK) phosphorylation after agonist stimulation.

Conclusion:  We identified the association of a genetic polymorphism in the intergenic region of with a decreased incidence of thrombocytopenia after CABG surgery. Because -an endogenous receptor tyrosine kinase inhibitor-is present in platelets and modulates essential signalling pathways, these findings support a role for as a novel modulator of platelet responses after cardiac surgery.

Citing Articles

Risk factors and prediction model for thrombocytopenia following coronary artery bypass graft surgery in elderly Chinese population.

Zhao H, Zhang W, Liu Y, Peng W J Thorac Dis. 2024; 16(1):273-284.

PMID: 38410552 PMC: 10894372. DOI: 10.21037/jtd-23-1396.

References
1.
Rosado J, Sage S . Role of the ERK pathway in the activation of store-mediated calcium entry in human platelets. J Biol Chem. 2001; 276(19):15659-65. DOI: 10.1074/jbc.M009218200. View

2.
Li Z, Xi X, Du X . A mitogen-activated protein kinase-dependent signaling pathway in the activation of platelet integrin alpha IIbbeta3. J Biol Chem. 2001; 276(45):42226-32. DOI: 10.1074/jbc.M106129200. View

3.
Singbartl K, Forlow S, Ley K . Platelet, but not endothelial, P-selectin is critical for neutrophil-mediated acute postischemic renal failure. FASEB J. 2001; 15(13):2337-44. DOI: 10.1096/fj.01-0199com. View

4.
Paparella D, Yau T, Young E . Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg. 2002; 21(2):232-44. DOI: 10.1016/s1010-7940(01)01099-5. View

5.
Delehanty L, Mogass M, Gonias S, Racke F, Johnstone B, Goldfarb A . Stromal inhibition of megakaryocytic differentiation is associated with blockade of sustained Rap1 activation. Blood. 2002; 101(5):1744-51. DOI: 10.1182/blood-2002-04-1278. View